TrianglePUBLICATIONS · 23650416
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2013 Jun 10
- First author
- Yardley DA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Yardley DA
- type
- Author
- name
- Ismail-Khan RR
- type
- Author
- name
- Melichar B
- type
- Author
- name
- Lichinitser M
- type
- Author
- name
- Munster PN
- type
- Author
- name
- Klein PM
- type
- Author
- name
- Cruickshank S
- type
- Author
- name
- Miller KD
- type
- Author
- name
- Lee MJ
- type
- Author
- name
- Trepel JB
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Yardley DA
- type
- Author
- name
- Ismail-Khan RR
- type
- Author
- name
- Melichar B
- type
- Author
- name
- Lichinitser M
- type
- Author
- name
- Munster PN
- type
- Author
- name
- Klein PM
- type
- Author
- name
- Cruickshank S
- type
- Author
- name
- Miller KD
- type
- Author
- name
- Lee MJ
- type
- Author
- name
- Trepel JB
- type
- Author
- bibliography ids
- nci-bib-79ad76a037eec3d88e8f2382
- book metadata
- content sha256
- 1a1d14402be4689ab10bca6ee14ae80f1d30beda454dd6520edf56e4844d5d18
- document type
- citation
- dois
- 10.1200/JCO.2012.43.7251
- electronic publication date
- display
- 2013 May 6
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23650416
- immutable id
- pubmed:23650416@1a1d14402be4689ab10bca6ee14ae80f1d30beda454dd6520edf56e4844d5d18
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 17
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2128-35
- volume
- 31
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23650416
- provenance
- batch id
- 99e008dabc339d38fd44
- provider
- NCBI PubMed ESummary
- record sha256
- a0e7ae131c35d5dc34461ec0ef1141bf9ed2796fb12e521036b78babdf664ead
- response sha256
- 804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
- retrieved at
- 2026-09-09T23:46:55.094762+00:00
- publication date
- display
- 2013 Jun 10
- precision
- day
- year
- 2013
- publication types
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor.
Preserved source evidence · Not medical advice